- Home
- RVPH vs NAAS Comparison
RVPH vs NAAS Comparison
Compare RVPH & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVPH | NAAS |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | United States | China |
| Employees | 14 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 25.4M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | RVPH | NAAS |
|---|---|---|
| Price | $0.21 | $2.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.14 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 6.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $378.49 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.41 |
| 52 Week High | $1.47 | $4.54 |
Technical Indicators
Market Signals| Indicator | RVPH | NAAS |
|---|---|---|
| Relative Strength Index (RSI) | 26.66 | 34.31 |
| Support Level | N/A | $0.55 |
| Resistance Level | $0.31 | $3.71 |
| Average True Range (ATR) | 0.02 | 0.13 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 10.43 | 8.49 |
Price Performance
Historical ComparisonAbout RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.